Inventor · disambiguated record
Peter F. Lebowitz
Also filed as: LEBOWITZ PETER · LEBOWITZ PETER F
6 granted patents·14 pending applications·38 citations·filing 2010–2022
80Inventor score
Top patents by PatentIndex Score
20 records- 0195US10869869B2Method of adjuvant cancer treatmentNOVARTIS AG·Filed 2019·Granted Dec 22, 2020·10 cites·3 claims
- 0293US8952018B2Pharmaceutical combination of MEK inhibitor and B-Raf inhibitorsGLAXOSMITHKLINE LLC·Filed 2014·Granted Feb 10, 2015·13 cites·5 claims
- 0391US8703781B2Pharmaceutical combination of MEK inhibitor and B-RAF inhibitorsDUMBLE MELISSA·Filed 2010·Granted Apr 22, 2014·14 cites·12 claims
- 0481US2023330091A1Method of Adjuvant Cancer TreatmentNOVARTIS AG·Filed 2022·Application pending·0 cites
- 0571US2021060021A1Method of Adjuvant Cancer TreatmentNOVARTIS AG·Filed 2020·Application pending·0 cites
- 0668US2015111904A1Pharmaceutical combination of mek inhibitor and b-raf inhibitorsGLAXOSMITHKLINE LLC·Filed 2014·Application pending·0 cites
- 0763US8796298B2Combination of a B-Raf inhibitor: N-{3-[5-(2-Amino-4-pyrimidinyl)-2-(1,1- dimethylethyl)-1,3-thiazol-4-yl]-2-fluorophenyl}-2,6-difluorobenzenesulfonamide and the Akt inhibitor: N-{ (1S)-2-amino-1-[(3- fluorophenyl)methyl]ethyl}-5-chIoro-4-(4-chIoro- 1 -methyl- 1 H-pyrazol-5-yl)-2-10 thiophenecarboxamide useful in the treatment of cancerDUMBLE MELISSA·Filed 2010·Granted Aug 5, 2014·1 cites·1 claims
- 0863US2018338979A1Method of Adjuvant Cancer TreatmentNOVARTIS AG·Filed 2018·Application pending·0 cites
- 0961US2015216868A1Method of Adjuvant Cancer TreatmentGLAXOSMITHKLINE LLC·Filed 2013·Application pending·0 cites
- 1059US2015094321A1CombinationGLAXOSMITHKLINE LLC·Filed 2014·Application pending·0 cites
- 1159US2017202842A1Method of Adjuvant Cancer TreatmentNOVARTIS AG·Filed 2017·Application pending·0 cites
- 1258US2014309243A1CombinationGLAXOSMITHKLINE LLC·Filed 2014·Application pending·0 cites
- 1356US2018214451A1CombinationNOVARTIS AG·Filed 2018·Application pending·0 cites
- 1455US9402846B2Combination of inhibitor of B-Raf and inhibitor of AKT in the treatment of cancerNOVARTIS AG·Filed 2014·Granted Aug 2, 2016·0 cites·15 claims
- 1550US2016143913A1CombinationNOVARTIS AG·Filed 2016·Application pending·0 cites
- 1648US2012283278A1CombinationDUMBLE MELISSA·Filed 2010·Application pending·0 cites
- 1745US8835450B2Combination of inhibitor of B-Raf and an inhibitor of Akt in the treatment of cancerDUMBLE MELISSA·Filed 2010·Granted Sep 16, 2014·0 cites·4 claims
- 1842US2015147350A1Method Of Treating Cancer With MEGEA3 Immunotherapeutic With BRAF Inhibitor And/Or MEK InhibitorGLAXOSMITHKLINE LLC·Filed 2012·Application pending·0 cites
- 1940US2012322817A1CombinationDUMBLE MELISSA·Filed 2010·Application pending·0 cites
- 2037US2013231346A1Methods of treating cancerGILMER TONA M·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Peter F. Lebowitz files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →